Basic Adoport Information

• INN (International Nonproprietary Name): Tacrolimus
• Brand Names Available In United Kingdom: Prograf®, Advagraf®, Tacni®, Modigraf®, Tacrolimus Sandoz®, Tacrolimus Accord®, Tacrolimus Mylan® (available brands and presentations per national procurement and hospital formularies)
• ATC Code: L04AD02
• Forms & Dosages: Immediate‑release capsules (0.5mg, 1mg, 5mg); granules for oral suspension (0.2mg, 1mg sachets); injection IV (5mg/mL vial); extended‑release tablets/capsules (0.5mg, 1mg, 3mg, 5mg).
• Manufacturers In United Kingdom: Not specified (global suppliers include Astellas Pharma, Sandoz, Mylan, Accord, Teva, Cipla; hospital procurement varies by trust).
• Registration Status In United Kingdom: Not specified (approved by EMA across Member States; national registration and local formularies determine available branded and generic products).
• OTC / Rx Classification: Rx only (prescription required).

Latest Research Highlights UK And EU 2022–2025

Worried about whether tacrolimus is still the backbone of modern transplant medicine?

Recent UK and EU cohort and registry reports between 2022 and 2025 continue to place tacrolimus as a leading calcineurin inhibitor for solid‑organ transplant immunosuppression.

Clinical themes emphasise lower rates of acute rejection compared with older ciclosporin‑based regimens when tacrolimus is used with standard adjuncts such as steroids and mycophenolate.

Therapeutic drug monitoring (TDM) and dose individualisation are central to recent practice updates, with genotype‑guided dosing (CYP3A5) increasingly used where available to refine early dose selection.

Safety monitoring has focused on metabolic complications such as new‑onset diabetes after transplant and on nephrotoxicity, prompting tighter early follow‑up.

EU multicentre cohorts report similar graft‑survival curves between immediate‑release and prolonged‑release formulations, with once‑daily prolonged‑release products linked to improved early adherence and steadier troughs in several analyses.

MHRA safety surveillance and Yellow Card trend reports have highlighted interaction clusters—notably with azole antifungals and macrolides—leading to urgent TDM and dose review recommendations.

Clinical Effectiveness In The UK

Are UK transplant teams still choosing tacrolimus for routine maintenance?

NHS and transplant‑centre audits from 2022–25 show tacrolimus‑based regimens provide consistent graft protection when paired with regular TDM and standard adjunct immunosuppression.

Data from NHS Blood And Transplant audits and unit reports indicate improved early graft survival and lower acute rejection compared with historical ciclosporin cohorts when tacrolimus is used.

However, new‑onset diabetes after transplant (NODAT), hypertension and nephrotoxicity remain clinically relevant adverse effects that require active management.

Patient‑reported outcome measures and forum feedback commonly report tremor, sleep disturbance and gastrointestinal upset as contributors to reduced quality of life and occasional non‑adherence.

• Common PROM Themes: Tremor; insomnia; nausea/diarrhoea; anxiety about infection risk; desire for clear TDM schedules and pharmacist support.

Practical UK practice includes routine trough monitoring in the first three months, pharmacist‑led adherence interventions and shared‑care via NHS electronic records.

Indications And Expanded Uses

What is tacrolimus officially licenced for, and when is off‑label use acceptable?

• MHRA/EMA‑Approved Indications: Prevention of organ rejection in kidney, liver, heart and lung transplantation (systemic formulations).
• Topical Licensed Uses: Topical tacrolimus formulations are licensed for dermatology indications (separate licence; topical product information applies).
• Off‑Label Systemic Use: Limited and specialist‑led—typically confined to tertiary centres for refractory autoimmune disorders; any systemic off‑label prescribing requires MDT agreement and informed consent.

Formulations are not interchangeable without clinical review; conversion between immediate‑release and extended‑release products requires fresh TDM and specialist supervision.

Composition And Brand Landscape

Which brands and pack types does the UK market see for tacrolimus?

Packaging includes blister packs or bottles (30–100), single‑dose granule sachets and injection vials (commonly 5mg/mL). Some packs are child‑resistant and provide light/temperature protection for transport and storage.

Contraindications And Special Precautions

Who should take extra care with tacrolimus?

Absolute Contraindication: Known hypersensitivity to tacrolimus or excipients.

• High‑Risk Groups Requiring Enhanced Surveillance: Severe hepatic impairment (dose reduction/longer intervals); renal impairment due to nephrotoxicity risk; the elderly (increased sensitivity); pregnant or breastfeeding patients (specialist review needed); patients with active severe infection or recent malignancy.

Daily‑Life Restrictions: Avoid driving or operating machinery if experiencing dizziness or marked tremor.

Alcohol can worsen metabolic adverse effects and may increase infection risk due to immunosuppression.

Vaccination Guidance: Live vaccines are contraindicated in markedly immunosuppressed patients—coordinate vaccination with the transplant team.

Dosage Guidelines

How is tacrolimus started and adjusted in NHS practice?

Initial dosing is weight‑based and individualised with early aggressive TDM to reach target trough concentrations.

1. Check trough concentration pre‑dose; adjust dose according to local protocol and clinical context.
2. Consider genotype (CYP3A5 expressors may need higher doses) where available.
3. When swapping formulations (immediate vs prolonged‑release), do not substitute without supervision and obtain new TDM.

Paediatric dosing is higher mg/kg and requires specialised paediatric transplant input.

Interactions Overview

What common medicines and foods change tacrolimus levels?

Tacrolimus is a CYP3A substrate and P‑glycoprotein substrate, so strong inhibitors and inducers of CYP3A have major effects on blood levels.

• Food Interaction: Avoid grapefruit and grapefruit juice because they can raise tacrolimus concentrations.
• Nephrotoxics: Co‑prescription with NSAIDs or aminoglycosides increases renal risk—monitor renal function closely.
• Practical Counselling: Always check new prescriptions, OTC medicines and herbal remedies with the transplant team or pharmacist before starting or stopping them.

MHRA Yellow Card reports have emphasised interaction clusters with azoles and macrolides, requiring urgent TDM and dose review where such combinations are used.

Cultural Perceptions And Patient Habits

Where do UK patients go for reliable information about tacrolimus?

Transplant patients in the UK commonly consult NHS pages, Patient.info and peer forums for practical advice and reassurance.

• Trusted Sources: Specialist nurses and community pharmacists are highly trusted for medication guidance.
• Patient Expectations: Clear TDM schedules, written regimen cards and pharmacist medication reviews—often at Boots, LloydsPharmacy or hospital pharmacy—are expected.
• Adherence Supports: Patients value electronic follow‑ups via the NHS App and EPS reminders, plus local transplant nurse helplines for urgent concerns.
• Supply Preference: Hospital supply remains primary for tacrolimus due to specialist dosing and TDM; online pharmacy growth is notable but hospital channels dominate for transplant medicines.

Checklist For Counselling

• Confirm dosing times and actions for missed doses.
• Explain TDM schedule and where bloods will be taken.
• Review interactions (especially azoles, macrolides, grapefruit).
• Provide written regimen card and transplant nurse contact details.

Availability And Pricing Patterns

How do patients in England, Scotland, Wales and Northern Ireland access tacrolimus?

Supply pathways are hospital‑centric for transplant patients; community pharmacies dispense repeat prescriptions issued by the GP under shared‑care arrangements or on hospital outpatient prescriptions.

In England NHS prescription charges may apply unless a patient is exempt; Scotland, Wales and Northern Ireland currently have mostly free prescriptions, creating regional differences in out‑of‑pocket cost and potential adherence impact.

Generics reduce procurement costs for NHS trusts and hospital tenders determine which brands are stocked locally.

Online pharmacies can offer home delivery and EPS convenience, but high‑risk immunosuppressants require secure supply chains and pharmacist review.

Note: our online pharmacy lists adoport for purchase without a prescription with discreet delivery across the United Kingdom in 5–14 days; patients should only use such services in line with shared‑care agreements and transplant team advice.

Comparable Medicines And Prescribing Preferences

When would clinicians choose alternatives to tacrolimus?

• Ciclosporin: Older calcineurin inhibitor; still used in some settings but tends to have higher acute rejection historically versus tacrolimus in comparative series.
• mTOR Inhibitors (Sirolimus, Everolimus): Considered for renal‑sparing strategies or malignancy risk modification, but carry wound‑healing delays and adverse lipid effects.

Pros And Cons Checklist

• Tacrolimus Pros: Lower acute rejection in many series; once‑daily extended‑release options improve adherence.
• Tacrolimus Cons: Nephrotoxicity risk; metabolic effects including diabetes; significant drug interactions requiring intensive monitoring.

Choice within the NHS is guided by transplant type, patient comorbidity and local formulary/tender decisions.

Frequently Asked Questions

Can my GP issue tacrolimus repeat prescriptions?

Usually yes under shared‑care agreements where the transplant centre manages initial dosing and TDM and the GP issues routine prescriptions in line with the agreed plan.

What should I do if I miss a dose?

Take the dose as soon as you remember if it is within a few hours of the usual time.

If it is close to the next dose, skip the missed dose and resume your regular schedule—do not double up.

Can I drink alcohol or take herbal supplements?

Alcohol may increase infection risk and worsen metabolic effects—discuss limits with your transplant team.

Avoid grapefruit and St John’s wort; check any herbal supplement with your pharmacist or transplant clinic before use.

How often will my blood be tested?

Very frequently in the first weeks (daily to weekly), then frequency reduces to monthly or every few months when stable—your centre will give a specific schedule.

When To Call The Transplant Team

• High fever or signs of infection.
• Markedly reduced urine output or sudden rise in creatinine.
• Severe tremor, confusion, seizures or visual changes.
• Any new medication (including OTC or prescribed antibiotics/antifungals) that might interact.

Guidelines For Proper Use

What should pharmacists tell patients when dispensing tacrolimus?

Counselling essentials include strict dosing times, why TDM matters, interaction checks (prescription and OTC), storage and not substituting formulations without clinician approval.

NHS‑Style Counselling Script

• Confirm patient identity and indication for tacrolimus.
• Review all current medicines including herbal supplements and OTCs.
• Explain the target trough range and arrange blood monitoring per transplant unit guidance.
• Advise on side‑effect red flags: fever, reduced urine, neurological changes, marked GI upset.
• Provide written regimen card, local transplant nurse contact and links to NHS transplant pages.

Storage and Missed Dose Highlights

• Store capsules and granules at 20–25°C, protect from moisture and light; do not refrigerate.
• If a dose is missed, take as soon as remembered within a few hours; otherwise skip—never double the dose.
• Do not substitute immediate‑release for extended‑release without clinician review and fresh TDM.

Delivery Across United Kingdom